Pura Vida Investments’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-52,573
Closed -$182K 226
2022
Q3
$182K Buy
+52,573
New +$201K 0.01% 183
2021
Q2
Sell
-68,792
Closed -$2.19M 259
2021
Q1
$2.19M Buy
+68,792
New +$1.67M 0.06% 156

Other funds holding MGNX

Pura Vida Investments's MGNX Position: Q4 2022 in Review

Pura Vida Investments sold out of MacroGenics (MGNX) in Q4 2022, closing a stake of 52,573 shares — an estimated $182K sold.

Pura Vida Investments first reported a position in MGNX in Q1 2021 and held it in 2 quarters. The position peaked at $2.19M in Q1 2021. 135 funds tracked by Wall St. Rank hold MGNX as of Q4 2022.

  • Pura Vida Investments reported no remaining MacroGenics position as of Q4 2022 after selling out during the quarter.
  • Pura Vida Investments sold 52,573 MacroGenics shares in Q4 2022, an estimated $182K.
  • Pura Vida Investments first reported a position in MacroGenics in Q1 2021 and held it in 2 quarters.
  • Pura Vida Investments's MacroGenics position peaked at $2.19M in Q1 2021.
  • 135 funds tracked by Wall St. Rank held MacroGenics as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.